JSMC-10395

ADVERSE OUTCOMES OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY AT GASTROENTEROLOGY AND HEPATOLOGY CENTERS IN SULAYMANIYAH AND DUHOK CITY

Hoshman Rahman Asaad a, Muhsin Abubakr Mohammed b, Ali A. Ramadhan c, Heero Ismael Faraj b , Mohammed Omar Mohammed d, Dana Taib Gharib c,

 Jutyar Aziz Husain a, and Ari Zuhair Sdiq a

Submitted: 27/5/2022; Accepted:21/10/2022; Published: 21/12/2023

a Kurdistan Board Trainee, Ministry of Health, Sulaimani, Kurdistan Region, Iraq.
b Kurdistan Center for Gastroenterology and Hepatology, Sulaimani, Kurdistan Region, Iraq.
c Azadi Center for Gastroenterology and Hepatology, Duhok, Kurdistan Region, Iraq.
d  College of Medicine, University of Sulaimani, Kurdistan Region, Iraq.

DOI Link: https://doi.org/10.17656/jsmc.10395 

---------------------------------------------------------------------------------------------------------------------------------------------------------------

ABSTRACT

Background 

Endoscopic retrograde cholangiopancreatography (ERCP) has a significant and managing management of pancreaticobiliary diseases in Iraq and Kurdistan. Evaluating ERCP adverse outcomes is essential in raising the effectiveness and safety of ERCP.

Objectives 

To review and measure the rate of ERCP complications in our centre and compare our results with other countries.

Patients and Methods

The present study was a prospective cross-sectional study carried out in the Kurdistan Center of Gastroenterology and Hepatology (KCGH) in Sulaimani city and Azadi Gastroenterology and Hepatology Center in Duhok city, Kurdistan region-Iraq through the period of one year from 1st of November 2020, to 31st of October, 2021 on a sample of two hundred patients underwent ERCP; 140 patients from Sulaimani city and 60 patients from Duhok city. The researcher followed up with the patients one month after completing ERCP through direct interviews or by phone calling to observe any ERCP adverse outcomes.

Results

The most typical indication for ERCP among studied patients was choledocholithiasis (43.7%), followed by; stent removal with occlusion cholangiography (12%) and biliary malignancy (11.6%). The commonest findings of ERCP among studied patients were bile duct dilation (42.3%), filling defects (33.8%) and bile duct strictures (14.7%). The post-ERCP complications were present in 45 (22.5%) patients, including pancreatitis (12.5%), cholangitis (4.5%), hypoxia (3.5%), bleeding (1.5%), perforation (1.5%) and death (0.5%). 

Conclusion

The adverse outcomes of ERCP in KCGH in Sulaimani City and the Gastroenterology and Hepatology centre in Duhok city are increased in the last year.

KEYWORDS

Endoscopic Retrograde Cholangiopancreatography, Adverse outcomes.

References 

1. Maple JT, Ikenberry SO, Anderson MA, Appalaneni V, Decker GA, Early D, et al; ASGE Standards of Practice Committee. The role of endoscopy in the management of choledocholithiasis. Gastrointest Endosc 2011; 74:731–744.

2. Anderson MA, Appalaneni V, Decker GA, Early DS, Evans JA, Fanelli RD, et al; ASGE Standards of Practice Committee. The role of endoscopy in the evaluation and treatment of patients with biliary neoplasia. Gastrointest Endosc 2013; 77:167–174. 

3. Chandrasekhara V, Chathadi KV, Acosta RD, Decker GA, Early DS, Eloubeidi MA, et al; ASGE Standards of Practice Committee. The role of endoscopy in benign pancreatic disease. Gastrointest Endosc 2015; 82:203–214.

4. Buxbaum JL, Abbas Fehmi SM, Sultan S, Fishman DS, Qumseya BJ, Cortessis VK, et al American Society for Gastrointestinal Endoscopy (ASGE) Standards of Practice Committee. ASGE guideline on the role of endoscopy in evaluating and managing choledocholithiasis. Gastrointest Endosc 2019; 89(6):1075-1105.e15. 

5. Salerno R, Mezzina N, Ardizzone S. Endoscopic retrograde cholangiopancreatography, lights and shadows: Handle with care. World J Gastrointest Endosc 2019; 11(3):219-230. 

6. Komanduri S, Thosani N, Aslanian HR, Enestvedt BK, Manfredi M, Maple JT, ASGE, et al; Standards of Practice Committee. Cholangiopancreatoscopy. Gastrointest Endosc 2016; 84: 209-221.

7. Keswani RN, Qumseya BJ, O'Dwyer LC, Wani S. Association Between Endoscopist and Center Endoscopic Retrograde Cholangiopancreatography Volume with Procedure Success and Adverse Outcomes: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2017; 15(12):1866-1875.e3.

8. Cotton PB, Eisen G, Romagnuolo J, Vargo J, Baron T, Tarnasky P, Schutz S et al. Grading the complexity of endoscopic procedures: results of an ASGE working party. Gastrointest Endosc 2011; 73: 868-874.

9. Chandrasekhara V, Khashab MA, Muthusamy VR, Acosta RD, Agrawal D, Bruining DH, et al; ASGE Standards of Practice Committee. Adverse events associated with ERCP. Gastrointest Endosc 2017; 85: 32-47.

10. Dumonceau JM, Andriulli A, Deviere J, Mariani A, Rigaux J, Baron TH, et al; European Society of Gastrointestinal Endoscopy. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy 2010; 42: 503-515.

11. Lyu Y, Cheng Y, Wang B, Xu Y, Du W. What is the impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials. BMC Gastroenterol 2018; 18: 106.

12. He X, Zheng W, Ding Y, Tang X, Si J, Sun LM. Rectal Indomethacin Is Protective against Pancreatitis after Endoscopic Retrograde Cholangiopancreatography: Systematic Review and Meta-Analysis. Gastroenterol Res Pract 2018; 2018: 9784841.

13. Lin WC, Lin HH, Hung CY, Shih SC, Chu CH. Clinical endoscopic management and outcome of post-endoscopic sphincterotomy bleeding. PLoS One 2017; 12(5):e0177449. 

14. Tavusbay C, Alper E, Gökova M, Kamer E, Kar H, Atahan K, et al. Management of perforation after endoscopic retrograde cholangiopancreatography. Ulus Travma Acil Cerrahi Derg 2016; 22 (5): 441-448.  

15. Alshekhani MA, Alkarbuli TA, Alqazi NAM, Hussein HA, Kasnazan QH, Ali AH. The Role of Endoscopic Retrograde Cholangiopancreatography (ERCP) in the Management of Intra-Biliary Rupture of Liver Hydatid Cysts (IBRH): Follow-Up of 12 Cases. Case Reports in Clinical Medicine 2014; 3: 533-543. Available from: http://dx.doi.org/10.4236/crcm.2014.39117

16. Qaradaghy SHS, Alkarbuli TA, Ramadhan AA, Abdullah HM, Hawramy TAH. Uses of endoscopic retrograde cholangiopancreatography in the management of post-cholecystectomy complications. Research 2017; 1: 770.

17. McCune WS, Shorb PE, Moscovitz H. Endoscopic cannulation of the Ampulla of Vater: a preliminary report. Ann Surg 1968; 167: 752–756. 

18. Woods KE, Willingham FF. Endoscopic retrograde cholangiopancreatography associated pancreatitis: A 15-year review. World J Gastrointest Endosc 2010; 2: 165–178.

19. Arslan U, Cayci HM. The Impact of Health Literacy on the ERCP Process. Turk J Int Med 2021; 3(3):134-140.

20. Alnajjar AF, Alkarboly TA, Ramadhan AA. The outcome of endoscopic retrograde cholangiopancreatography at Kurdistan Center for Gastroenterology and Hepatology. JSMC 2015; 5 (2): 95-100.

21. Hormati A, Aminnejad R, Saeidi M, Ghadir MR, Mohammadbeigi A, Shafiee H. Prevalence of Anesthetic and Gastrointestinal Complications of Endoscopic Retrograde Cholangiopancreatography. Anesth Pain Med 2019; 9(4):e95796. 

22. Kröner PT, Bilal M, Samuel R. Use of ERCP in the United States over the past decade. Endosc Int Open 2020; 8(6):E761-E769. 

23. Tamura T, Ogura T, Takenaka M, Tanioka K, Itonaga M, Yamao K, et al. Endoscopic sphincterotomy to prevent post-ERCP pancreatitis in patients with biliary neoplasms: a multicenter retrospective cohort study. Endosc Int Open 2020; 8(4):E513-E522. 

24. Chen X, Wang F, Liu J, Tao W, Zhang Z, Cao T, et al. Risk factors for adverse events associated with endoscopic retrograde cholangiopancreatography in patients with surgically altered anatomy: a retrospective study. BMC Gastroenterol 2021; 21: 448. Available from: https://doi.org/10.1186/s12876-021-02031-w

25. Lee HJ, Cho CM, Heo J, Jung MK, Kim TN, Kim KH, et al. Impact of Hospital Volume and the Experience of Endoscopists on Adverse Events Related to Endoscopic Retrograde Cholangiopancreatography: A Prospective Observational Study. Gut Liver 2020; 14(2):257-264. 

26. Mohammad Alizadeh AH, Afzali ES, Shahnazi A, Sanati A, Mirsattari D, Zali MR. Utility and safety of ERCP in the elderly: a comparative study in Iran. Diagn Ther Endosc 2012; 2012:439320. 

27. Kochar B, Akshintala VS, Afghani E, Elmunzer BJ, Kim KJ, Lennon AM, et al. Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest Endosc 2015; 81(1):143-149.e9.

28. Yildirim AE. ERCP-related bleeding. J Exp Clin Med 2021; 38(S1): 44-52.

29. Koc B, Bircan HY, Adas G, Kemik O, Akcakaya A. Complications Following Endoscopic Retrograde Cholangiopancreatography: Minimal Invasive Surgical Recommendations. PLoS ONE 2014; 9(11): e113073.

30. Vezakis A, Fragulidis G, Polydorou A. Endoscopic retrograde cholangiopancreatography-related perforations: Diagnosis and management. World J Gastrointest Endosc 2015; 7(14):1135-1141. 

31. Madani S, Taghavi R, Saiidi M, Vafaeimanesh J. Bilateral pneumothorax: The cause of hypoxia during endoscopic retrograde cholangiopancreatography. Caspian J Intern Med 2021; 12(Suppl 2): S426-S430. 

32. Peixoto A, Silva M, Macedo G. Cholangitis after endoscopic retrograde cholangiopancreatography: a rare complication? Rev Esp Enferm Dig 2017; 109 (7): 536-537.

33. Sharma A, Mossad D, Markert RJ. ERCP is associated with greater morbidity and mortality when compared to laparoscopic cholecystectomy. American Journal of Gastroenterology 2017; 112: S18-S19.

Full Text